Navigation Links
Vista Partners Updates Coverage; Maintains $3.20 Target Price
Date:4/1/2008

LOS ANGELES, April 1, 2008 /PRNewswire/ -- Vista Partners announced today that it has updated its coverage on American Bio Medica Corporation (Nasdaq: ABMC) and maintains its twelve month target price of $3.20. Ross Silver, Director of Research at Vista Partners stated, "Sales internationally continue to increase and sales from ABMC's lab alliance, which give ABMC's products exposure in numerous testing centers, continue to increase as well. Once the company receives CLIA approval from the FDA, we believe ABMC's valuation will increase dramatically."

About Vista Partners:

Vista Partners provides independent, equity research to institutional and individual investors, with a focus on publicly traded small capitalization companies. With offices in Los Angeles and San Francisco, Vista Partners is one of the fastest growing independently owned equity research firms. Vista Partners professional staff has backgrounds in finance, corporate communications and investment banking. More information is available at http://www.vistap.com.

About American Bio Medica:

American Bio Medica Corporation is a biotechnology company that develops, manufactures and markets accurate, cost-effective immunoassay diagnostic test kits, including some of the world's most effective point of collection tests for drugs of abuse. The Company and its worldwide distribution network target the workplace, government, corrections, clinical and educational markets. ABMC's Rapid Drug Screen(R), Rapid One(R), Rapid TEC(R), RDS(R) InCup(R), Rapid TOX(R) and Rapid TOX Cup(TM) products test for the presence or absence of drugs of abuse in urine, while OralStat(R) and Rapid STAT(TM) tests for the presence or
'/>"/>

SOURCE Vista Partners LLC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Bayer HealthCare Pharmaceuticals Introduces VistaTrak(TM) an Innovative Contrast Media Management System
2. Synvista Therapeutics Highlights Newly Published Data Demonstrating the Value of Haptoglobin Genotype Testing In People with Diabetes
3. Vista Partners Updates Coverage on Inovio Biomedical Corporation (Amex: INO) With $3.52 Price Target
4. Renovo Announces Results of Latest Phase 2 Studies of JUVISTA(R) (Human Recombinant TGFbeta3)
5. Synvista Therapeutics to Present at the 10th Annual BIO CEO & Investor Conference
6. Synvista Therapeutics to Develop Topical Formulation of ALT-2074 for the Treatment of Psoriasis
7. Provista Awards Agreement to Spheris
8. Synvista Therapeutics to be Featured on Wallst.net
9. Synvista Therapeutics to Present at the BIO InvestorForum 2007
10. OncoVista, Inc. Closes on $6.8 Million Financing and Acquires Control of a Public Shell Company
11. Expiry of Hart-Scott-Rodino Waiting Period for JUVISTA(R) (Human TGF BETA 3)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... ... 31, 2015 , ... Global Resorcinol Market 2015-2019 is a ... the global resorcinol industry. The report highlights the various growth prospects and the ... analysis of primary and secondary inputs from the existing players of the resorcinol ...
(Date:7/31/2015)... ... July 31, 2015 , ... R-Biopharm is proud ... partially hydrolyzed gluten in foods, has been accepted by AOAC International as Official ... Gluten in Fermented Cereal-Based Products by R5 Competitive ELISA,” based on a specific ...
(Date:7/30/2015)... 30, 2015 AACC welcomed thousands of ... AACC Annual Meeting & Clinical Lab Expo in ... The meeting showcased revolutionary advancements in clinical testing ... healthcare providers to diagnose patients quickly and accurately ... As of Wednesday, July 29, ...
(Date:7/30/2015)... USA (PRWEB) , ... July 30, 2015 , ... ... microsystems, has appointed Francois Vieillard as Sales & Marketing Director. , With ... Francois Vieillard will be responsible for reinforcing Tronics’ business development activities worldwide. He ...
Breaking Biology Technology:Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 2Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 3Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 4RIDASCREEN® Competitve Gliadin Receives AOAC Official First Action Status 2Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 2Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 3Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 4Tronics appoints Francois Vieillard as Sales and Marketing Director 2
... Hitech(TM), a focus area of,SAFC(R) and part of ... that it will be participating in a webcast, ... to discuss,the subject of Atomic Layer Deposition (ALD). ... (NAND and NOR) technologies that could be,addressed by ...
... system treats cancer, patients quickly and ... OAK, Mich., Oct. 30 Beaumont Hospital, Royal ... treatments using the new,Elekta Axesse(TM), the ultimate whole-body ... precision and therapeutic efficacy in,stereotactic radiation therapy, which ...
... Diagnostics Grows 9.4%; On Target to ... Achieve Full Year Outlook, ... a leading developer, manufacturer and marketer of,products that simplify, automate and ... results. Total,revenue of $669 million was up 6.0% over third quarter ...
Cached Biology Technology:SAFC Hitech(TM) Joins Aviza and ST Microelectronics for Solid State Technology ALD Webcast 2SAFC Hitech(TM) Joins Aviza and ST Microelectronics for Solid State Technology ALD Webcast 3Beaumont Hospital, Royal Oak Treats Its First Patients With Elekta Axesse 2Beaumont Hospital, Royal Oak Treats Its First Patients With Elekta Axesse 3Beaumont Hospital, Royal Oak Treats Its First Patients With Elekta Axesse 4Beckman Coulter Announces Third Quarter 2007 Results 2Beckman Coulter Announces Third Quarter 2007 Results 3Beckman Coulter Announces Third Quarter 2007 Results 4Beckman Coulter Announces Third Quarter 2007 Results 5Beckman Coulter Announces Third Quarter 2007 Results 6Beckman Coulter Announces Third Quarter 2007 Results 7Beckman Coulter Announces Third Quarter 2007 Results 8Beckman Coulter Announces Third Quarter 2007 Results 9Beckman Coulter Announces Third Quarter 2007 Results 10Beckman Coulter Announces Third Quarter 2007 Results 11Beckman Coulter Announces Third Quarter 2007 Results 12Beckman Coulter Announces Third Quarter 2007 Results 13Beckman Coulter Announces Third Quarter 2007 Results 14Beckman Coulter Announces Third Quarter 2007 Results 15Beckman Coulter Announces Third Quarter 2007 Results 16Beckman Coulter Announces Third Quarter 2007 Results 17Beckman Coulter Announces Third Quarter 2007 Results 18Beckman Coulter Announces Third Quarter 2007 Results 19Beckman Coulter Announces Third Quarter 2007 Results 20Beckman Coulter Announces Third Quarter 2007 Results 21Beckman Coulter Announces Third Quarter 2007 Results 22Beckman Coulter Announces Third Quarter 2007 Results 23Beckman Coulter Announces Third Quarter 2007 Results 24Beckman Coulter Announces Third Quarter 2007 Results 25
(Date:7/2/2015)... , June 25, 2015 ... the addition of the "Natural Language Processing ... (Recognition, IVR, OCR, Pattern & Image Recognition) - ... offering. The key vendors occupying the ... IBM Corporation, Microsoft Corporation, NetBase Solutions, SAS Institute ...
(Date:7/2/2015)... 2, 2015 Fingerprint Cards has received ... and FPC1155 from the distributor World Peace Industrial Group (WPI), ... in Asia . Deliveries are planned to ... be used by smartphone manufacturers in Asia ... the communicated revenue guidance of approximately 2,200 MSEK for 2015. ...
(Date:6/30/2015)... , June 30, 2015 Genisphere ... company as CEO to help further develop Genisphere,s therapeutics ... of partnering experience, having spent much of the last ... Therakine, Amgen, Baxter Bioscience, and Johnson & Johnson. Tom ... on Technology and Biotech Corporate Finance. He graduated from ...
Breaking Biology News(10 mins):Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2FPC Receives Order for Touch Fingerprint Sensors of 268 MSEK 2Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3
... A team of researchers from the Wildlife Conservation Society (WCS) ... South American sea bird called an imperial cormorant with a ... diving 150 feet underwater in 40 seconds, feeding on the ... snakelike fish, before returning to the surface 40 seconds later. ...
... Cold feetthose chilly appendages that plague many people in ... the bane of existence for singles and couples alike. In ... the Research Institute at Nationwide Children,s Hospital have identified a ... interaction between a series of molecules and receptors on smooth ...
... improve low cost methods for carbon capture. Scientists from ... synchrotron to investigate the efficiency of calcium oxide (CaO) ... published in the journal of Energy & Environmental ... key mechanisms involved. This new knowledge will inform efforts ...
Cached Biology News:Are cold feet plaguing your relationship? 2Are cold feet plaguing your relationship? 3Low-cost carbon capture gets X-rayed 2Low-cost carbon capture gets X-rayed 3
Rabbit polyclonal to Quinaldic Acid ( Abpromise for all tested applications). Antigen: Synthetic peptide Quinaldic Acid conjugated to a protein carrier....
... N-terminal kinase (JNK) is one of the ... has been used as a sensitive reporter ... provides a 1000-fold increase in sensitivity in ... assay. Firefly luciferase catalyzes the oxidative carboxylation ...
... number is a new product ... Cornings product number. If showing ... under the old Sigma-Aldrich number ... for assistance. ID clarifier: filling ...
... number is a new product ... Cornings product number. If showing ... under the old Sigma-Aldrich number ... for assistance. ID clarifier: cap, ...
Biology Products: